CULTZYME ’s Post

Centralisation of information and decentralisation of operation are key factors that will advance the synthetic biology ecosystem in all its verticals. At CULTZYME we are committed to providing a unique tool in its field that will democratise synthetic biology. Check out our recent article European Biopharmaceutical Review (EBR) on how our technologies are shaping the next era of bioprocessing. #CULTZYME #intelligentbioprocessing

Payer pushback on the high cost of hemophilia cell and gene therapies is reflected in the quality of their coverage. https://ow.ly/JUsF50TNWm0 MMIT’s Andrew Rouff discusses the factors behind the slow uptake of these curative therapies in this blog. Click the link in this post for the insights. #Hemophilia #HemophiliaTreatments #CGTs

#mediacoverage Businessworld published an authored article by aditi thakur, Analyst, Technology Research & Advisory - How Gene Therapy Is Paving the Way For A Cure For Type 1 Diabetes. Type 1 diabetes (T1D) arises from a complex interplay of #genetic predisposition and #environmental triggers, leading to an #autoimmune assault on insulin-producing beta cells in the pancreas. Read more: https://lnkd.in/fQupV7s #aranca #arancainsights #diabetes #genetherapy #autoimmunedisease #cure #type1diabetes

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx

In our final roundtable—the last in a three-part series—we discuss considerations for incorporating #CompanionDiagnostic strategies into the development of cell and gene therapies. #CellTherapy #GeneTherapy #PrecisionMedicine #CDx